Vallo Varik has joined the Estonian Biofoundry team within DigiBio to drive innovation. Following his postdoctoral research in systems microbiology at the Nassos Typas lab at EMBL Heidelberg, where he focused on high-throughput approaches to discover and characterize novel antibacterial treatments, Varik is eager to advance data-driven approaches in synthetic biology.
He was drawn to the Institute of Bioengineering’s newly established team because of its emphasis on lab automation, cutting-edge data science, and potential to become a leading centre for groundbreaking biological research and development. Varik is excited to leverage his experience with high-throughput approaches to advance drug discovery and engineer designer cells for next-generation biosustainable solutions. He sees the Estonian Biofoundry as a unique opportunity to introduce novel infrastructure for Estonian life scientists and build international partnerships.